<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine Maintenance Dose: Why 3-5g/Day Works for Most People</title>
  <meta name="description" content="Research-backed analysis of creatine maintenance dosing. Covers the 3-5g/day recommendation, daily creatine turnover rates, body weight considerations, and...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatinepedia.com/dosing/creatine-maintenance-dose">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatinepedia.com/dosing/creatine-maintenance-dose">
  <meta property="og:title" content="Creatine Maintenance Dose: Why 3-5g/Day Works for Most People">
  <meta property="og:description" content="Research-backed analysis of creatine maintenance dosing. Covers the 3-5g/day recommendation, daily creatine turnover rates, body weight considerations, and...">
  <meta property="og:site_name" content="Creatinepedia">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine Maintenance Dose: Why 3-5g/Day Works for Most People">
  <meta name="twitter:description" content="Research-backed analysis of creatine maintenance dosing. Covers the 3-5g/day recommendation, daily creatine turnover rates, body weight considerations, and...">
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the physiology of creatine turnover?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The human body contains a total creatine pool of approximately 120-140 g in a 70 kg individual. Of this, roughly 95% resides in skeletal muscle, with the remainder distributed across the brain, kidneys, liver, and testes. Each day, approximately 1.7% of the total creatine and phosphocreatine pool undergoes irreversible, non-enzymatic degradation to creatinine, which is then excreted by the kidneys. For a person with a total pool of 120 g, this equates to roughly 2 g/day of creatine turnover."
      }
    },
    {
      "@type": "Question",
      "name": "Why 3-5 g/Day Is Sufficient?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The maintenance dose recommendation of 3-5 g/day originates from the work of Hultman et al. (1996), who demonstrated that after a five-day loading phase of 20 g/day, a subsequent daily dose of 2 g was sufficient to maintain elevated muscle creatine stores over a 28-day monitoring period. They noted that slightly higher doses (3-5 g/day) provided a greater margin of safety for individuals with larger muscle mass or higher turnover rates."
      }
    },
    {
      "@type": "Question",
      "name": "What are the body weight and muscle mass considerations?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The 3-5 g/day range implicitly accounts for variation in body size. A 60 kg individual with moderate muscle mass has a smaller total creatine pool and lower absolute daily turnover than a 100 kg individual with substantial lean mass. The lighter person can maintain saturated stores near the lower end of the range (3 g/day), while the heavier person may benefit from the upper end (5 g/day) or even slightly more."
      }
    },
    {
      "@type": "Question",
      "name": "What is the long-term maintenance data?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "One of the most frequently asked questions about creatine supplementation is whether it remains effective and safe over months and years of continuous use. The evidence on this point is robust. Kreider et al. (2003) followed competitive athletes supplementing with creatine for up to 21 months and reported no adverse effects on any clinical health marker, including renal function, hepatic enzymes, lipid profiles, and hematological parameters."
      }
    },
    {
      "@type": "Question",
      "name": "Does Endogenous Synthesis Downregulate?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A persistent concern is whether chronic exogenous creatine intake suppresses the body's own creatine production. The AGAT enzyme, which catalyzes the first step of endogenous creatine synthesis, is subject to feedback inhibition by creatine. In vitro and animal studies have confirmed that elevated intracellular creatine concentrations reduce AGAT expression and activity."
      }
    }
  ]
}
  </script>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">pedia</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">New Entries</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">The Creatine Encyclopedia</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">100 entries. Every claim cited from peer-reviewed sources. No marketing. No supplement sales.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Start Reading
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get New Entries</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/dosing" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Dosing Protocols</a>
      </div>
    </div>
    <div class="article-body">
      <article>
    <header>
      <nav aria-label="Breadcrumb">
        <ol>
          <li><a href="/">Home</a></li>
          <li><a href="/dosing">Dosing Protocols</a></li>
          <li aria-current="page">Creatine Maintenance Dose</li>
        </ol>
      </nav>
      <h1>Creatine Maintenance Dose: Why 3-5g/Day Works for Most People</h1>
      <p>After muscle creatine stores reach saturation, a daily maintenance dose replaces what the body naturally degrades. This article examines the physiological basis for the 3-5g/day recommendation, individual variation based on body mass, and what long-term data tells us about sustained supplementation.</p>
      <time datetime="2026-01-28">January 28, 2026</time>
    </header>

    <section>
      <h2>The Physiology of Creatine Turnover</h2>
      <p>The human body contains a total creatine pool of approximately 120-140 g in a 70 kg individual. Of this, roughly 95% resides in skeletal muscle, with the remainder distributed across the brain, kidneys, liver, and testes. Each day, approximately 1.7% of the total creatine and phosphocreatine pool undergoes irreversible, non-enzymatic degradation to creatinine, which is then excreted by the kidneys. For a person with a total pool of 120 g, this equates to roughly 2 g/day of creatine turnover.</p>
      <p>Under normal dietary conditions, the body replaces this daily loss through two pathways. Endogenous synthesis, primarily in the liver and kidneys via the arginine-glycine amidinotransferase (AGAT) and guanidinoacetate N-methyltransferase (GAMT) enzyme system, produces approximately 1 g/day. Dietary intake from meat and fish contributes an additional 1-2 g/day in omnivores, though this figure varies substantially depending on food choices. Vegetarians receive negligible dietary creatine, relying entirely on endogenous synthesis.</p>
      <p>When muscle creatine stores are elevated through supplementation (from approximately 120 to 150 mmol/kg dry weight), the daily turnover rate increases in absolute terms because it is proportional to the total pool size. The elevated pool of roughly 140-160 g produces approximately 2.4-2.7 g/day of creatinine. Maintaining these elevated stores therefore requires replacing this higher absolute loss.</p>
    </section>

    <section>
      <h2>Why 3-5 g/Day Is Sufficient</h2>
      <p>The maintenance dose recommendation of 3-5 g/day originates from the work of Hultman et al. (1996), who demonstrated that after a five-day loading phase of 20 g/day, a subsequent daily dose of 2 g was sufficient to maintain elevated muscle creatine stores over a 28-day monitoring period. They noted that slightly higher doses (3-5 g/day) provided a greater margin of safety for individuals with larger muscle mass or higher turnover rates.</p>
      <p>The International Society of Sports Nutrition (ISSN) formalized this recommendation in their 2017 position stand (Kreider et al., 2017), stating that a maintenance dose of 3-5 g/day of creatine monohydrate is effective for sustaining intramuscular creatine elevations in most individuals. The position stand drew on over two decades of supplementation trials and concluded that this dose range is both safe and effective for long-term use.</p>
      <p>The arithmetic supports the recommendation. If daily turnover is approximately 2-2.7 g from the total pool, and endogenous synthesis replaces roughly 1 g of that, the exogenous replacement need is approximately 1-1.7 g/day at minimum. However, oral creatine bioavailability is not 100%. While absorption from the gut is generally high (estimated at 80-99% depending on the study), not all absorbed creatine reaches muscle tissue. Some is excreted renally before muscle uptake can occur. A dose of 3-5 g/day therefore provides a comfortable buffer above the calculated minimum requirement.</p>
    </section>

    <section>
      <h2>Body Weight and Muscle Mass Considerations</h2>
      <p>The 3-5 g/day range implicitly accounts for variation in body size. A 60 kg individual with moderate muscle mass has a smaller total creatine pool and lower absolute daily turnover than a 100 kg individual with substantial lean mass. The lighter person can maintain saturated stores near the lower end of the range (3 g/day), while the heavier person may benefit from the upper end (5 g/day) or even slightly more.</p>
      <p>Kreider et al. (2017) noted that relative dosing of approximately 0.03 g/kg/day provides a more individualized estimate for maintenance. For a 70 kg person, this equals 2.1 g/day; for a 90 kg person, 2.7 g/day; and for a 110 kg person, 3.3 g/day. These calculated values are somewhat lower than the blanket 3-5 g recommendation, suggesting that the higher end of the range includes a safety margin. Given the negligible cost and absence of adverse effects at these doses, the practical recommendation of 3-5 g/day remains appropriate for simplicity.</p>
      <p>Individuals with exceptionally high lean body mass (e.g., competitive bodybuilders above 100 kg) may theoretically benefit from 5-10 g/day to account for their larger creatine pool. However, direct evidence supporting maintenance doses above 5 g/day in any population is limited, and the ISSN position stand does not recommend exceeding 5 g/day for maintenance purposes in the general population.</p>
    </section>

    <section>
      <h2>Long-Term Maintenance Data</h2>
      <p>One of the most frequently asked questions about creatine supplementation is whether it remains effective and safe over months and years of continuous use. The evidence on this point is robust. Kreider et al. (2003) followed competitive athletes supplementing with creatine for up to 21 months and reported no adverse effects on any clinical health marker, including renal function, hepatic enzymes, lipid profiles, and hematological parameters.</p>
      <p>Longer observational data exist. Poortmans and Francaux (1999) evaluated renal function in athletes who had been supplementing with creatine for periods ranging from 10 months to 5 years. They found no evidence of renal dysfunction as assessed by glomerular filtration rate, tubular reabsorption, or glomerular membrane permeability. Serum creatinine was modestly elevated (an expected consequence of increased creatine stores and turnover), but this did not reflect impaired kidney function.</p>
      <p>The ISSN position stand (Kreider et al., 2017) concluded that creatine monohydrate is the most studied and clinically effective form of creatine for use in nutritional supplements, with a strong safety profile across all populations studied. They explicitly stated that long-term supplementation (up to five years) has been studied and appears safe in healthy individuals when taken at recommended doses.</p>
    </section>

    <section>
      <h2>Does Endogenous Synthesis Downregulate?</h2>
      <p>A persistent concern is whether chronic exogenous creatine intake suppresses the body's own creatine production. The AGAT enzyme, which catalyzes the first step of endogenous creatine synthesis, is subject to feedback inhibition by creatine. In vitro and animal studies have confirmed that elevated intracellular creatine concentrations reduce AGAT expression and activity.</p>
      <p>However, this suppression is reversible. Cessation of exogenous creatine supplementation leads to a return of endogenous synthesis to baseline levels within weeks. Vandenberghe et al. (1997) documented that muscle creatine levels returned to pre-supplementation values within four to six weeks of ceasing supplementation, and this timeline is consistent with restored endogenous production. There is no evidence in humans that chronic creatine supplementation permanently impairs the body's ability to synthesize creatine.</p>
      <p>From a clinical perspective, the temporary reduction in endogenous synthesis during supplementation is actually metabolically favorable. Creatine synthesis is metabolically expensive, consuming methyl groups from S-adenosylmethionine (SAM) and requiring arginine and glycine as substrates. Reducing this synthetic burden frees methyl groups and amino acids for other metabolic processes. Brosnan et al. (2011) estimated that creatine synthesis accounts for approximately 40% of all SAM-derived methyl groups in the body, making exogenous supplementation a meaningful reduction in methylation demand.</p>
    </section>

    <section>
      <h2>Maintenance Without Prior Loading</h2>
      <p>An important clarification: the 3-5 g/day maintenance dose is not exclusively a follow-up to loading. As Hultman et al. (1996) demonstrated, taking 3 g/day without any loading phase gradually elevates muscle creatine stores over approximately 28 days until they reach the same saturation level achieved by loading. After that point, continued intake of 3-5 g/day serves the same maintenance function regardless of how saturation was initially achieved.</p>
      <p>This means the distinction between "loading" and "maintenance" is primarily one of timeline. The maintenance dose is the long-term daily intake that matches turnover. If started from unsupplemented baseline, this dose will simultaneously saturate and maintain. If started after loading, it maintains the already-saturated state. The biochemical endpoint is identical.</p>
    </section>

    <section>
      <h2>Timing of the Maintenance Dose</h2>
      <p>At the maintenance level of 3-5 g/day, timing is less pharmacokinetically critical than during loading. A single daily dose produces a plasma creatine peak that is cleared within several hours, but because the goal is to replace approximately 2 g of daily turnover (not to rapidly fill a deficit), consistent daily intake matters more than precise timing.</p>
      <p>That said, some evidence suggests modest advantages to post-exercise timing. Antonio and Ciccone (2013) reported small but statistically significant benefits in lean mass and strength when creatine was consumed immediately after resistance training compared to immediately before. The proposed mechanism involves exercise-induced increases in muscle blood flow and creatine transporter activity. However, the effect size is small, and the practical significance for the average user is marginal. The most important factor is daily consistency.</p>
    </section>

    <section>
      <h2>What Happens If You Miss Days</h2>
      <p>Missing occasional doses has minimal impact on intramuscular stores. Because the creatine pool is large (120-160 g) and turnover is slow (approximately 2 g/day), a single missed day reduces the pool by roughly 1-2 g (the shortfall between turnover loss and endogenous synthesis alone). This represents less than 2% of the total pool. Even missing several consecutive days will not meaningfully deplete stores, provided supplementation is resumed promptly.</p>
      <p>Complete cessation of supplementation, however, leads to a gradual return to baseline over approximately four to six weeks (Vandenberghe et al., 1997). This timeline is consistent with the daily turnover rate depleting the 20-40 g of additional creatine stored during supplementation. Regular daily intake is therefore preferable, but occasional missed doses are inconsequential.</p>
    </section>

    <section>
      <h2>Practical Recommendations</h2>
      <p>The maintenance protocol is straightforward:</p>
      <ol>
        <li>Consume 3-5 g of creatine monohydrate daily. For most individuals (60-90 kg), 3-5 g is appropriate. Larger individuals (above 90 kg) may benefit from staying at the upper end.</li>
        <li>Take the dose at a consistent time each day to build a sustainable habit. With meals is practical but not required.</li>
        <li>Dissolve in water, juice, or any beverage. Creatine monohydrate is stable in solution for reasonable periods.</li>
        <li>Continue indefinitely. There is no evidence-based reason to cycle off maintenance dosing.</li>
        <li>Do not exceed 5 g/day for maintenance. Higher doses provide no additional benefit once stores are saturated and simply increase renal excretion.</li>
      </ol>
    </section>

    <section>
      <h2>Summary</h2>
      <p>The 3-5 g/day maintenance dose is grounded in the physiology of creatine turnover. The body degrades approximately 2 g of creatine daily, and a 3-5 g exogenous dose — after accounting for endogenous synthesis and bioavailability losses — reliably replaces this deficit and sustains elevated intramuscular stores. Long-term safety data spanning years of continuous use support indefinite supplementation at this dose. The recommendation is consistent across the ISSN position stand, meta-analyses, and two decades of clinical trials.</p>
    </section>

    <section>
      <h2>Bibliography</h2>
      <ol>
        <li>Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. <em>Journal of Applied Physiology</em>. 1996;81(1):232-237. doi:10.1152/jappl.1996.81.1.232. PMID: 8828669.</li>
        <li>Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. <em>Journal of the International Society of Sports Nutrition</em>. 2017;14:18. doi:10.1186/s12970-017-0173-z. PMID: 28615996.</li>
        <li>Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. <em>Molecular and Cellular Biochemistry</em>. 2003;244(1-2):95-104. doi:10.1023/A:1022469320296. PMID: 12701816.</li>
        <li>Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. <em>Medicine and Science in Sports and Exercise</em>. 1999;31(8):1108-1110. doi:10.1097/00005768-199908000-00005. PMID: 10449011.</li>
        <li>Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. <em>Journal of Applied Physiology</em>. 1997;83(6):2055-2063. doi:10.1152/jappl.1997.83.6.2055. PMID: 9390981.</li>
        <li>Antonio J, Ciccone V. The effects of pre versus post workout supplementation of creatine monohydrate on body composition and strength. <em>Journal of the International Society of Sports Nutrition</em>. 2013;10:36. doi:10.1186/1550-2783-10-36. PMID: 23919405.</li>
        <li>Brosnan JT, da Silva RP, Brosnan ME. The metabolic burden of creatine synthesis. <em>Amino Acids</em>. 2011;40(5):1325-1331. doi:10.1007/s00726-011-0853-y. PMID: 21387089.</li>
      </ol>
    </section>
      
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>What is the physiology of creatine turnover?</h3>
          <p>The human body contains a total creatine pool of approximately 120-140 g in a 70 kg individual. Of this, roughly 95% resides in skeletal muscle, with the remainder distributed across the brain, kidneys, liver, and testes. Each day, approximately 1.7% of the total creatine and phosphocreatine pool undergoes irreversible, non-enzymatic degradation to creatinine, which is then excreted by the kidneys. For a person with a total pool of 120 g, this equates to roughly 2 g/day of creatine turnover.</p>
        </div>
        <div class="faq-item">
          <h3>Why 3-5 g/Day Is Sufficient?</h3>
          <p>The maintenance dose recommendation of 3-5 g/day originates from the work of Hultman et al. (1996), who demonstrated that after a five-day loading phase of 20 g/day, a subsequent daily dose of 2 g was sufficient to maintain elevated muscle creatine stores over a 28-day monitoring period. They noted that slightly higher doses (3-5 g/day) provided a greater margin of safety for individuals with larger muscle mass or higher turnover rates.</p>
        </div>
        <div class="faq-item">
          <h3>What are the body weight and muscle mass considerations?</h3>
          <p>The 3-5 g/day range implicitly accounts for variation in body size. A 60 kg individual with moderate muscle mass has a smaller total creatine pool and lower absolute daily turnover than a 100 kg individual with substantial lean mass. The lighter person can maintain saturated stores near the lower end of the range (3 g/day), while the heavier person may benefit from the upper end (5 g/day) or even slightly more.</p>
        </div>
        <div class="faq-item">
          <h3>What is the long-term maintenance data?</h3>
          <p>One of the most frequently asked questions about creatine supplementation is whether it remains effective and safe over months and years of continuous use. The evidence on this point is robust. Kreider et al. (2003) followed competitive athletes supplementing with creatine for up to 21 months and reported no adverse effects on any clinical health marker, including renal function, hepatic enzymes, lipid profiles, and hematological parameters.</p>
        </div>
        <div class="faq-item">
          <h3>Does Endogenous Synthesis Downregulate?</h3>
          <p>A persistent concern is whether chronic exogenous creatine intake suppresses the body's own creatine production. The AGAT enzyme, which catalyzes the first step of endogenous creatine synthesis, is subject to feedback inhibition by creatine. In vitro and animal studies have confirmed that elevated intracellular creatine concentrations reduce AGAT expression and activity.</p>
        </div>
      </section>
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current with Creatinepedia</h3>
        <p>Get notified when new entries are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get New Entries</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/dosing/creatine-dosing-protocols-summary">Complete Dosing Guide: Dosing Protocols</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/dosing" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Dosing Protocols</a>
        </div>
        <a href="/dosing" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">New Entries & Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New encyclopedia entries and updates — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatinepedia</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">The creatine encyclopedia. 100 entries cited from peer-reviewed sources.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">New Entries</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatinepedia. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>